UK becomes first country to approve dual-strain covid-19 vaccine

UK becomes first country to approve dual-strain covid-19 vaccine

The UK has become the first country in the world to approve a new dual-strain vaccine that targets both the original covid-19 virus and the omicron variant.

Manufactured by Moderna, who has said it can start to provide doses in the coming weeks, the new vaccine is expected to be rolled out this autumn ahead of the winter flu season. It is hoped the vaccine will also provide greater protection against other variants yet to be seen.

Research showed the new vaccine, known as a bivalent because it specifically targets two different strains at the same time, was approved for use in adults by the UK’s medicines and Healthcare Products Regulatory Agency.

Chief executive of the MHRA, Dr June Raine, said: “The first generation of Covid-19 vaccines being used in the UK continue to provide important protection against the disease and save lives.

“What this bivalent vaccine gives us is a sharpened tool in our armoury to help protect us against this disease as the virus continues to evolve.”

Stéphane Bancel, Moderna CEO, added: “This represents the first authorisation of an Omicron-containing bivalent vaccine. This bivalent vaccine has an important role to play in protecting people in the UK from Covid-19 as we enter the winter months.”

Results showed an increase of antibodies able to stick to and disable the first of the omicron variants, BA.1, whilst improved protection was also recorded against later variants, BA.4 and BA.5.

Since it first appeared in China in 2019, the Covid-19 virus has mutated several times resulting in a number of different, and virulent, strains that have placed massive pressure on healthcare regimes around the world.

Leave a reply

Your email address will not be published. Required fields are marked *

Aether: Issue 3 Feb 2023

Aether: Issue 2 Nov 2022

Aether: Issue 1 Aug 2022

Subscribe for free

Latest Testimonial

What a beautiful motto: Discoveries must be read and not just published. When I was contacted by Aether as a new digital service to share scientific and technological insights I had my doubts that this was really going to be according to what I call the “open source & makers’ spirit”: knowledge should be free and it is there to be shared.

Well, Aether is faithful to its motto and shares discoveries freely. It has been a pleasure to collaborate for the interview and subsequent article. It has been greatly self satisfying to see how the interview was professionally and truthfully redacted and then published. Sharing thoughts and sparks for discussions is fundamental to the progress of society. Your journal offers clarity and brevity and I believe it provides the sparks to ignite any reader whether academic or not into action.

Dr Maria-Cristina Ciocci
Co-founder and Manager of non-profit organisation De Creative STEM,GirlsInSTEM